Serveur d'exploration sur Pittsburgh

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Matching wits with melanoma brain metastases: from biology to therapeutics.

Identifieur interne : 002256 ( Main/Exploration ); précédent : 002255; suivant : 002257

Matching wits with melanoma brain metastases: from biology to therapeutics.

Auteurs : Hussein Tawbi [États-Unis]

Source :

RBID : pubmed:25135484

Descripteurs français

English descriptors

Abstract

Melanoma brain metastases (MBM) present a significant clinical challenge. Molecular profiling of MBM is useful to identify molecular pathways, such as the PI3K pathway, that are specifically and differentially altered in MBM. Therapeutic studies should recruit patients with MBM and prospective tissue collection will lay the foundation for further advances.

DOI: 10.1158/1078-0432.CCR-14-1121
PubMed: 25135484


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Matching wits with melanoma brain metastases: from biology to therapeutics.</title>
<author>
<name sortKey="Tawbi, Hussein" sort="Tawbi, Hussein" uniqKey="Tawbi H" first="Hussein" last="Tawbi">Hussein Tawbi</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. University of Pittsburgh Cancer Institute Melanoma and Skin Cancer Program, Pittsburgh, Pennsylvania. tawbih@upmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. University of Pittsburgh Cancer Institute Melanoma and Skin Cancer Program, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25135484</idno>
<idno type="pmid">25135484</idno>
<idno type="doi">10.1158/1078-0432.CCR-14-1121</idno>
<idno type="wicri:Area/PubMed/Corpus">001195</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001195</idno>
<idno type="wicri:Area/PubMed/Curation">001189</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001189</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001189</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001189</idno>
<idno type="wicri:Area/Ncbi/Merge">003031</idno>
<idno type="wicri:Area/Ncbi/Curation">003031</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003031</idno>
<idno type="wicri:doubleKey">1078-0432:2014:Tawbi H:matching:wits:with</idno>
<idno type="wicri:Area/Main/Merge">002348</idno>
<idno type="wicri:Area/Main/Curation">002256</idno>
<idno type="wicri:Area/Main/Exploration">002256</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Matching wits with melanoma brain metastases: from biology to therapeutics.</title>
<author>
<name sortKey="Tawbi, Hussein" sort="Tawbi, Hussein" uniqKey="Tawbi H" first="Hussein" last="Tawbi">Hussein Tawbi</name>
<affiliation wicri:level="2">
<nlm:affiliation>Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. University of Pittsburgh Cancer Institute Melanoma and Skin Cancer Program, Pittsburgh, Pennsylvania. tawbih@upmc.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea>Division of Hematology/Oncology, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. University of Pittsburgh Cancer Institute Melanoma and Skin Cancer Program, Pittsburgh</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical cancer research : an official journal of the American Association for Cancer Research</title>
<idno type="ISSN">1078-0432</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Brain Neoplasms (genetics)</term>
<term>Brain Neoplasms (pathology)</term>
<term>Humans</term>
<term>Melanoma (genetics)</term>
<term>Melanoma (pathology)</term>
<term>Neoplasm Metastasis (genetics)</term>
<term>Phosphatidylinositol 3-Kinases (genetics)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Humains</term>
<term>Mélanome (anatomopathologie)</term>
<term>Mélanome (génétique)</term>
<term>Métastase tumorale (génétique)</term>
<term>Phosphatidylinositol 3-kinases (génétique)</term>
<term>Tumeurs du cerveau (anatomopathologie)</term>
<term>Tumeurs du cerveau (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Phosphatidylinositol 3-Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Mélanome</term>
<term>Tumeurs du cerveau</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Brain Neoplasms</term>
<term>Melanoma</term>
<term>Neoplasm Metastasis</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Mélanome</term>
<term>Métastase tumorale</term>
<term>Phosphatidylinositol 3-kinases</term>
<term>Tumeurs du cerveau</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Brain Neoplasms</term>
<term>Melanoma</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Melanoma brain metastases (MBM) present a significant clinical challenge. Molecular profiling of MBM is useful to identify molecular pathways, such as the PI3K pathway, that are specifically and differentially altered in MBM. Therapeutic studies should recruit patients with MBM and prospective tissue collection will lay the foundation for further advances.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Tawbi, Hussein" sort="Tawbi, Hussein" uniqKey="Tawbi H" first="Hussein" last="Tawbi">Hussein Tawbi</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002256 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002256 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:25135484
   |texte=   Matching wits with melanoma brain metastases: from biology to therapeutics.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:25135484" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PittsburghV1 

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021